Nutrition and Cognition in Aging Adults

Clinics in Geriatric Medicine

Volumn 31, Issue 3, 2015, Pages 453-464

  Coley, Nicola ^a,b,c   Vaurs, Charlotte ^a,b,c   Andrieu, Sandrine ^a,b,c  

^a UMR INSERM 1027   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Antioxidants; Cognitive decline; Dementia; Nutrients; Polyunsaturated fatty acids; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID DERIVATIVE; FOLIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PLACEBO; POLYPHENOL DERIVATIVE; POLYUNSATURATED FATTY ACID; SELENIUM; VITAMIN B GROUP; VITAMIN D; XANTHOPHYLL;

ADULT; AGING; ALZHEIMER DISEASE; CALORIC RESTRICTION; COGNITIVE DEFECT; COHORT ANALYSIS; DEMENTIA; DIETARY INTAKE; EVIDENCE BASED MEDICINE; FAT INTAKE; FEEDING BEHAVIOR; HUMAN; LIFESTYLE; LONGITUDINAL STUDY; MEDITERRANEAN DIET; META ANALYSIS (TOPIC); MILD COGNITIVE IMPAIRMENT; MULTICENTER STUDY (TOPIC); NUTRITIONAL DISORDER; NUTRITIONAL STATUS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW (TOPIC); VITAMIN SUPPLEMENTATION; AGED; COGNITION; COGNITION DISORDERS; HEALTH BEHAVIOR; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; PSYCHOLOGY;

AGED; AGING; COGNITION; COGNITION DISORDERS; FOOD HABITS; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; NUTRITIONAL STATUS; PREVALENCE;

EID: 84945473967     PISSN: 07490690     EISSN: 18798853     Source Type: Journal    
DOI: 10.1016/j.cger.2015.04.008     Document Type: Review

References (85)

1. Prince M., Bryce R., Albanese E., et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 2013, 9:63-75.e2.
2. Prince M., Albanese E., Guerchet M., et al. World Alzheimer report 2014 dementia and risk reduction: an analysis of protective and modifiable factors 2014, Alzheimer's Disease International, London.
3. Joseph J., Cole G., Head E., et al. Nutrition, brain aging, and neurodegeneration. J Neurosci 2009, 29:12795-12801.
4. Markesbery W.R., Carney J.M. Oxidative alterations in Alzheimer's disease. Brain Pathol 1999, 9:133-146.
5. Bishop N.A., Lu T., Yankner B.A. Neural mechanisms of ageing and cognitive decline. Nature 2010, 464:529-535.
6. Li F.J., Shen L., Ji H.F. Dietary intakes of vitamin E, vitamin C, and beta-carotene and risk of Alzheimer's disease: a meta-analysis. J Alzheimers Dis 2012, 31:253-258.
7. Rafnsson S.B., Dilis V., Trichopoulou A. Antioxidant nutrients and age-related cognitive decline: a systematic review of population-based cohort studies. Eur J Nutr 2013, 52:1553-1567.
8. Petersen R.C., Thomas R.G., Grundman M., et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005, 352:2379-2388.
9. Kang J.H., Cook N., Manson J., et al. A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 2006, 166:2462-2468.
10. Kang J.H., Cook N.R., Manson J.E., et al. Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the women's antioxidant and cardiovascular study. Circulation 2009, 119:2772-2780.
11. Smith A., Clarke R., Nutt D., et al. Anti-oxidant vitamins and mental performance of the elderly. Hum Psychopharmacol 1999, 14:459-471.
12. Kesse-Guyot E., Fezeu L., Jeandel C., et al. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. Am J Clin Nutr 2011, 94:892-899.
13. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:23-33.
14. Yaffe K., Clemons T.E., McBee W.L., et al. Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial. Neurology 2004, 63:1705-1707.
15. Grodstein F., Kang J.H., Glynn R.J., et al. A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch Intern Med 2007, 167:2184-2190.
16. Kryscio R.J., Abner E.L., Schmitt F.A., et al. A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE Trial. J Nutr Health Aging 2013, 17:72-75.
17. Barnes J.L., Tian M., Edens N.K., et al. Consideration of nutrient levels in studies of cognitive decline. Nutr Rev 2014, 72:707-719.
18. Morris M.C., Evans D.A., Tangney C.C., et al. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr 2005, 81:508-514.
19. Bjelakovic G., Nikolova D., Gluud L.L., et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007, 297:842-857.
20. Stevenson D.E., Hurst R.D. Polyphenolic phytochemicals-just antioxidants or much more?. Cell Mol Life Sci 2007, 64:2900-2916.
21. Cherniack E.P. A berry thought-provoking idea: the potential role of plant polyphenols in the treatment of age-related cognitive disorders. Br J Nutr 2012, 108:794-800.
22. Ghosh D., Scheepens A. Vascular action of polyphenols. Mol Nutr Food Res 2009, 53:322-331.
23. Scalbert A., Johnson I.T., Saltmarsh M. Polyphenols: antioxidants and beyond. Am J Clin Nutr 2005, 81:215S-217S.
24. Davinelli S., Sapere N., Zella D., et al. Pleiotropic protective effects of phytochemicals in Alzheimer's disease. Oxid Med Cell Longev 2012, 2012:386527.
25. Ho L., Chen L.H., Wang J., et al. Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration. J Alzheimers Dis 2009, 16:59-72.
26. Wang J., Ferruzzi M.G., Ho L., et al. Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment. J Neurosci 2012, 32:5144-5150.
27. Piazza-Gardner A.K., Gaffud T.J., Barry A.E. The impact of alcohol on Alzheimer's disease: a systematic review. Aging Ment Health 2013, 17:133-146.
28. Ng T.P., Feng L., Niti M., et al. Tea consumption and cognitive impairment and decline in older Chinese adults. Am J Clin Nutr 2008, 88:224-231.
29. Kesse-Guyot E., Fezeu L., Andreeva V.A., et al. Total and specific polyphenol intakes in midlife are associated with cognitive function measured 13 years later. J Nutr 2012, 142:76-83.
30. Desideri G., Kwik-Uribe C., Grassi D., et al. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging (CoCoA) study. Hypertension 2012, 60:794-801.
31. Camfield D.A., Scholey A., Pipingas A., et al. Steady state visually evoked potential (SSVEP) topography changes associated with cocoa flavanol consumption. Physiol Behav 2012, 105:948-957.
32. Crews W.D., Harrison D.W., Wright J.W. A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults. Am J Clin Nutr 2008, 87:872-880.
33. Krikorian R., Nash T.A., Shidler M.D., et al. Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. Br J Nutr 2010, 103:730-734.
34. Krikorian R., Boespflug E.L., Fleck D.E., et al. Concord grape juice supplementation and neurocognitive function in human aging. J Agric Food Chem 2012, 60:5736-5742.
35. Pipingas A., Silberstein R.B., Vitetta L., et al. Improved cognitive performance after dietary supplementation with a Pinus radiata bark extract formulation. Phytother Res 2008, 22:1168-1174.
36. Uauy R., Dangour A.D. Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev 2006, 64:S24-S33. [discussion: S72-91].
37. Gillette-Guyonnet S., Secher M., Vellas B. Nutrition and neurodegeneration: epidemiological evidence and challenges for future research. Br J Clin Pharmacol 2013, 75:738-755.
38. Dangour A.D., Whitehouse P.J., Rafferty K., et al. B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review. J Alzheimers Dis 2010, 22:205-224.
39. Fotuhi M., Mohassel P., Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol 2009, 5:140-152.
40. Sydenham E., Dangour A.D., Lim W.S. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev 2012, (6). CD005379.
41. Yurko-Mauro K., McCarthy D., Rom D., et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 2010, 6:456-464.
42. Johnson E.J., McDonald K., Caldarella S.M., et al. Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr Neurosci 2008, 11:75-83.
43. Sinn N., Milte C.M., Street S.J., et al. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr 2012, 107:1682-1693.
44. Andreeva V.A., Kesse-Guyot E., Barberger-Gateau P., et al. Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. Am J Clin Nutr 2011, 94:278-286.
45. Williams J., Plassman B., Burke J., et al. Preventing Alzheimer's disease and cognitive decline. Evidence report/technology assessment no. 193. (Prepared by the Duke Evidence-Based Practice Center under contract no. HHSA 290-2007-10066-I.) AHRQ publication no. 10-E005 2010, Agency for Healthcare Research and Quality, Rockville (MD).
46. Danthiir V., Burns N.R., Nettelbeck T., et al. The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults. Nutr J 2011, 10:117.
47. Manson J.E., Bassuk S.S., Lee I.M., et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2012, 33:159-171.
48. Vellas B., Carrie I., Gillette-Guyonnet S., et al. MAPT study: a multidomain approach for preventing Alzheimer's disease: design and baseline data. J Prev Alzheimers Disease 2014, 1:13-22.
49. Kruman I.I., Kumaravel T.S., Lohani A., et al. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 2002, 22:1752-1762.
50. Nie T., Lu T., Xie L., et al. Hyperhomocysteinemia and risk of cognitive decline: a meta-analysis of prospective cohort studies. Eur Neurol 2014, 72:241-248.
51. Wald D.S., Kasturiratne A., Simmonds M. Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants. Alzheimers Dement 2011, 7:412-417.
52. Beydoun M.A., Beydoun H.A., Gamaldo A.A., et al. Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health 2014, 14:643.
53. Doets E.L., van Wijngaarden J.P., Szczecinska A., et al. Vitamin B12 intake and status and cognitive function in elderly people. Epidemiol Rev 2013, 35:2-21.
54. 12 status, cognitive decline and dementia: a systematic review of prospective cohort studies. Br J Nutr 2012, 108:1948-1961.
55. Ford A.H., Almeida O.P. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis 2012, 29:133-149.
56. Smith A.D., Smith S.M., de Jager C.A., et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One 2010, 5:e12244.
57. de Jager C.A., Oulhaj A., Jacoby R., et al. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry 2012, 27:592-600.
58. Flicker L., Martins R.N., Thomas J., et al. B-vitamins reduce plasma levels of beta amyloid. Neurobiol Aging 2008, 29:303-305.
59. Morris M.C., Tangney C.C. A potential design flaw of randomized trials of vitamin supplements. JAMA 2011, 305:1348-1349.
60. Durga J., van Boxtel M.P., Schouten E.G., et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007, 369:208-216.
61. McMahon J.A., Green T.J., Skeaff C.M., et al. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006, 354:2764-2772.
62. Otaegui-Arrazola A., Amiano P., Elbusto A., et al. Diet, cognition, and Alzheimer's disease: food for thought. Eur J Nutr 2014, 53:1-23.
63. McCann J.C., Ames B.N. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?. FASEB J 2008, 22:982-1001.
64. Annweiler C., Montero-Odasso M., Llewellyn D.J., et al. Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J Alzheimers Dis 2013, 37:147-171.
65. Ozawa M., Ninomiya T., Ohara T., et al. Dietary patterns and risk of dementia in an elderly Japanese population: the Hisayama Study. Am J Clin Nutr 2013, 97:1076-1082.
66. Barberger-Gateau P., Raffaitin C., Letenneur L., et al. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 2007, 69:1921-1930.
67. Bullo M., Lamuela-Raventos R., Salas-Salvado J. Mediterranean diet and oxidation: nuts and olive oil as important sources of fat and antioxidants. Curr Top Med Chem 2011, 11:1797-1810.
68. Cicerale S., Lucas L.J., Keast R.S. Antimicrobial, antioxidant and anti-inflammatory phenolic activities in extra virgin olive oil. Curr Opin Biotechnol 2012, 23:129-135.
69. Lourida I., Soni M., Thompson-Coon J., et al. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology 2013, 24:479-489.
70. Martinez-Lapiscina E.H., Clavero P., Toledo E., et al. Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized, trial. J Nutr Health Aging 2013, 17:544-552.
71. Kwok T.C., Lam L.C., Sea M.M., et al. A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents. Eur J Clin Nutr 2012, 66:1135-1140.
72. Santoro A., Pini E., Scurti M., et al. Combating inflammaging through a Mediterranean whole diet approach: the NU-AGE project's conceptual framework and design. Mech Ageing Dev 2014, 136-137:3-13.
73. Feart C., Samieri C., Barberger-Gateau P. Mediterranean diet and cognitive health: an update of available knowledge. Curr Opin Clin Nutr Metab Care 2015, 18:51-62.
74. Mattson M.P. The impact of dietary energy intake on cognitive aging. Front Aging Neurosci 2010, 2:5.
75. Kishi T., Hirooka Y., Nagayama T., et al. Calorie restriction improves cognitive decline via up-regulation of brain-derived neurotrophic factor. Int Heart J 2014, 56:110-115.
76. Martin C.K., Anton S.D., Han H., et al. Examination of cognitive function during six months of calorie restriction: results of a randomized controlled trial. Rejuvenation Res 2007, 10:179-190.
77. Brinkworth G.D., Buckley J.D., Noakes M., et al. Long-term effects of a very low-carbohydrate diet and a low-fat diet on mood and cognitive function. Arch Intern Med 2009, 169:1873-1880.
78. Gold D., Andres D., Etezadi J., et al. Structural equation model of intellectual change and continuity and predictors of intelligence in older men. Psychol Aging 1995, 10:294-303.
79. Coley N., Andrieu S., Gardette V., et al. Dementia prevention: methodological explanations for inconsistent results. Epidemiol Rev 2008, 30:35-66.
80. Caracciolo B., Xu W., Collins S., et al. Cognitive decline, dietary factors and gut-brain interactions. Mech Ageing Dev 2014, 136-137:59-69.
81. Green R.C., Dekosky S.T. Primary prevention trials in Alzheimer disease. Neurology 2006, 67:S2-S5.
82. Dangour A.D., Allen E., Richards M., et al. Design considerations in long-term intervention studies for the prevention of cognitive decline or dementia. Nutr Rev 2010, 68(Suppl 1):S16-S21.
83. Luchsinger J.A., Mayeux R. Dietary factors and Alzheimer's disease. Lancet Neurol 2004, 3:579-587.
84. Scarmeas N., Luchsinger J.A., Schupf N., et al. Physical activity, diet, and risk of Alzheimer disease. JAMA 2009, 302:627-637.
85. Kivipelto M., Solomon A., Ahtiluoto S., et al. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement 2013, 9:657-665.